AtaiBeckley (ATAI) Enterprise Value (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Enterprise Value of -$43.8 million for Q1 2026, down 7465.46% year-over-year from $594722.0 in Q1 2025, and up 48.57% quarter-over-quarter from -$85.2 million in Q4 2025.
AtaiBeckley (ATAI) Enterprise Value (2020 - 2026) Analysis & Trends
AtaiBeckley's Enterprise Value history runs 3 years deep, the most recent figure standing at -$43.8 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 7465.46% year-over-year to -$43.8 million; the TTM figure through Mar 2026 stood at -$43.8 million (down 19920.81% YoY), while the FY2025 annual figure was -$85.2 million, down 212.58% from the prior year.
- Enterprise Value for Q1 2026 stood at -$43.8 million, up from -$85.2 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$27.2 million in Q4 2024 and troughed at -$450.5 million in Q2 2021.
- A 5-year average of -$136.5 million and a median of -$75.7 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2025 and 2026: Enterprise Value slumped 212.58% in 2025, then tumbled 7465.46% in 2026.
- AtaiBeckley's Enterprise Value stood at -$27.2 million in 2024, then plunged by 212.58% to -$85.2 million in 2025, then surged by 48.57% to -$43.8 million in 2026.
- Business Quant data shows ATAI's Enterprise Value at -$43.8 million in Q1 2026, -$85.2 million in Q4 2025, and -$579000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | AtaiBeckley | 2.69 Bn | 2.69 Bn | - | -30.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -168.74 Mn |
| Mar 31, 2026 | -43.80 Mn |
| Dec 31, 2025 | -85.17 Mn |
| Sep 30, 2025 | -30.25 Mn |
| Jun 30, 2025 | -61.75 Mn |
| Mar 31, 2025 | -48.87 Mn |
| Mar 31, 2025 | -579,000.00 |
| Dec 31, 2024 | -27.25 Mn |
| Dec 31, 2024 | -27.25 Mn |
| Sep 30, 2024 | -59.37 Mn |
| Jun 30, 2024 | -48.69 Mn |
| Mar 31, 2024 | -38.15 Mn |
| Dec 31, 2023 | -43.68 Mn |
| Sep 30, 2023 | -74.26 Mn |
| Jun 30, 2023 | -138.01 Mn |
| Mar 31, 2023 | -182.07 Mn |
| Dec 31, 2022 | -186.69 Mn |
| Sep 30, 2022 | -135.86 Mn |
| Jun 30, 2022 | -75.69 Mn |
| Mar 31, 2022 | -115.62 Mn |